Percutaneous Computed Tomography–guided High-Dose-Rate Brachytherapy Ablation of Breast Cancer Liver Metastases: Initial Experience with 80 Lesions
Authors:
- 1 May 2012
- journal article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 23 (5) , 618-626
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hepatic metastases from breast cancerUpdates in Surgery, 2010
- Loco‐regional treatment of hepatocellular carcinoma†Hepatology, 2010
- Hepatic Resection for Liver Metastases as Part of the “Oncosurgical” Treatment of Metastatic Breast CancerAnnals of Surgical Oncology, 2008
- Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)The Lancet Oncology, 2008
- Five-year Survival following Radiofrequency Ablation of Small, Solitary, Hepatic Colorectal MetastasesJournal of Vascular and Interventional Radiology, 2008
- Is Liver Resection Justified for Patients With Hepatic Metastases From Breast Cancer?Annals of Surgery, 2006
- A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast CancerThe Oncologist, 2003
- Percutaneous Radio-frequency Ablation of Liver Metastases from Breast Cancer: Initial Experience in 24 PatientsRadiology, 2001
- Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patientsBreast Cancer Research and Treatment, 1999
- Chemotherapy of advanced breast cancer: outcome and prognostic factorsBritish Journal of Cancer, 1993